Cargando…
Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation
Advanced glycation end products (AGEs) may induce cardiac remodeling in kidney disease by promoting fibroblast growth factor 23 (FGF-23) expression. Since AGEs are increased in diabetes mellitus (DM), our first aim was to evaluate the existence of any potential association between AGEs, FGF-23, infl...
Autores principales: | Dozio, Elena, Corradi, Valentina, Vianello, Elena, Scalzotto, Elisa, de Cal, Massimo, Corsi Romanelli, Massimiliano Marco, Ronco, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632909/ https://www.ncbi.nlm.nih.gov/pubmed/29147074 http://dx.doi.org/10.1155/2017/9845175 |
Ejemplares similares
-
Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients
por: Dozio, Elena, et al.
Publicado: (2018) -
AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
por: Molinari, Paolo, et al.
Publicado: (2021) -
In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
por: Caldiroli, Lara, et al.
Publicado: (2022) -
Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis
por: Wu, Rui, et al.
Publicado: (2020) -
Circulating Irisin and esRAGE as Early Biomarkers of Decline of Metabolic Health
por: Dozio, Elena, et al.
Publicado: (2020)